Last Updated: September 24, 2026

Suppliers and packagers for TROPHAMINE


✉ Email this page to a colleague

« Back to Dashboard


TROPHAMINE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
B Braun TROPHAMINE amino acids INJECTABLE;INJECTION 019018 NDA B. Braun Medical Inc. 0264-1933-10 12 CONTAINER in 1 CASE (0264-1933-10) / 500 mL in 1 CONTAINER 2020-10-27
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for TROPHAMINE

Last updated: June 2, 2026

Trophamine suppliers: Who manufactures, supplies, and sells TROPHAMINE for pharmaceutical use?

No sufficiently specific, source-backed dataset is available in this context to identify named suppliers for TROPHAMINE (including API vs excipient suppliers, contract manufacturers, distributor channels, or country-specific manufacturing sites), nor to map those suppliers to regulatory listings (e.g., FDA DMF, EU ASMF) or to the Orange Book/NDC supply chain.

Which companies supply TROPHAMINE as an API for pharmaceutical formulations?

Answer: Not determinable from the information provided.

API vs excipient supply: how TROPHAMINE is typically sourced

  • Not determinable from the information provided.
  • No verified supplier list, manufacturing status, or documentation (DMF/ASMF) can be produced from the information provided.

Are there contract manufacturers (CMOs) making TROPHAMINE products under toll or custom synthesis?

Answer: Not determinable from the information provided.

Manufacturing method and site disclosures

  • Not determinable from the information provided.

What distributors sell TROPHAMINE into pharma and chemical supply channels?

Answer: Not determinable from the information provided.

Warehouse/distribution scope by region

  • Not determinable from the information provided.

How does TROPHAMINE supply chain differ between jurisdictions (US vs EU vs China/India)?

Answer: Not determinable from the information provided.

Regulatory documentation that drives sourcing

  • Not determinable from the information provided.

What documents (DMF, ASMF, CoA, specifications) do TROPHAMINE suppliers provide?

Answer: Not determinable from the information provided.

Typical quality package

  • Not determinable from the information provided.

How many TROPHAMINE suppliers are there, and what is the concentration risk?

Answer: Not determinable from the information provided.

Supplier concentration and single-site risks

  • Not determinable from the information provided.

How strong is the supplier qualification landscape for TROPHAMINE (audits, GMP, inspections)?

Answer: Not determinable from the information provided.

GMP status and compliance signals

  • Not determinable from the information provided.

Which TROPHAMINE raw-material grades are supplied for pharmaceutical use (anhydrous, solution, salt form)?

Answer: Not determinable from the information provided.

Specification-driven sourcing

  • Not determinable from the information provided.

Key Takeaways

  • A verified, named supplier roster for TROPHAMINE cannot be produced from the information provided in this context.
  • API vs excipient sourcing, CMO toll manufacturing, distributor channels, and quality documentation cannot be mapped to specific entities without source-backed listings.

FAQs

  1. What is the fastest way to find TROPHAMINE suppliers for pharma-grade material?
    Not determinable from the information provided.

  2. Do TROPHAMINE suppliers typically hold US DMFs or EU ASMFs?
    Not determinable from the information provided.

  3. Can pharma suppliers source TROPHAMINE in powder form versus solution?
    Not determinable from the information provided.

  4. What are typical TROPHAMINE impurity/spec controls suppliers must meet?
    Not determinable from the information provided.

  5. Are there known supplier shortages or backorders for TROPHAMINE?
    Not determinable from the information provided.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.